Contribute Try STAT+ Today

Is Alzheimer’s research stuck in a rut? Can genome editing live up to the hype? And how will we remember Operation Warp Speed?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We’re devoting this episode to the news coming out of the just-concluded J.P. Morgan Healthcare Conference, the drug industry’s largest annual meeting. First, we’ll dissect Eli Lilly’s surprising data on a new Alzheimer’s disease treatment and dig into its implications for the field. Then, we discuss whether there’s a bubble inflating in the genome editing world, debate who will run the FDA under a President Biden, and consider the legacy of Moncef Slaoui, the outgoing leader of Operation Warp Speed.

For more on what we cover, here’s the Alzheimer’s news from Lilly; here’s the latest on Slaoui; and here’s our complete coverage of the coronavirus pandemic.

advertisement

Be sure to sign up on Apple PodcastsStitcherGoogle Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

advertisement


Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].